Be a part of 3^rd International Conference on Hypertension

1. Hypertension and Cardiovascular Risk
Examination of the relationship between hypertension and cardiovascular disease, and strategies for integrated management to reduce overall cardiovascular risk.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

2. Hypertension in Diabetic Patients
Discussion on the challenges of managing hypertension in patients with diabetes, recent research findings, and effective treatment strategies.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

3. Hypertension and Chronic Kidney Disease
Analysis of the impact of hypertension on chronic kidney disease progression, current treatment guidelines, and management strategies for patients with both conditions.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

4. Pathophysiology of Hypertension
This session will explore the complex mechanisms behind blood pressure regulation, including the role of the renin-angiotensin-aldosterone system (RAAS), the impact of genetic factors, and the influence of environmental elements such as diet and lifestyle.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

5. Pediatric Hypertension
Discussion on the diagnosis, management, and long-term implications of hypertension in children and adolescents, including current guidelines and treatment options.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

6. Hypertension and Mental Health
Exploration of the link between hypertension and mental health conditions such as anxiety and depression, and integrated management approaches for these comorbid conditions.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

7. Hypertension and Obesity
Discussion on the interrelationship between hypertension and obesity, the impact of weight reduction on blood pressure, and effective management strategies.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

8. Hypertension During Pregnancy
Discussion on the prevalence and impact of hypertension in pregnancy, management strategies for gestational hypertension and preeclampsia, medication safety, and monitoring and follow-up care.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

9. Pulmonary Hypertension
Pulmonary hypertension is a condition where the blood pressure in the pulmonary arteries, which carry blood from the heart to the lungs, is higher than normal.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

10. Telemedicine and Remote Care
Exploration of the implementation and benefits of telemedicine in hypertension management, including remote care models, case studies of successful programs, and discussions on regulatory and reimbursement issues.
Hypertension Meetings 2025 | Cardiology Events 2054 | Obesity Congress 2025 | Hypertension and Blood pressure conferences 2025 | Hypertension symposium 2025

Globally, Hypertension or high Blood Pressure leads to 7.5million death cases which shares about 12.8% of all death cases recorded. Hypertension is also accounts about 57million disabilities adjusted life years which is about 3.7% of total adjusted life years. Hypertension is the primary risk factor of coronary heart disease, ischemic & hemorrhagic stroke.
As per the research of some independent firm, global Hypertension drug market is estimated to be $24.7billion in 2018 & expected to hit about $19.3 billion by 2029 with an annual CAGR of -2.3% in between 2019 to 2029. As per the estimation of WHO, globally more than 1.13 billion of people are affected with Hypertension among which less than 1 in each 5 is under control. Unhealthy diets, lack of physical activities, consumption of alcohol & tobacco are the main contributing factors of Hypertension. To reduce the prevalence by 25% by 2025, WHO along with United States Center for Disease Control and Prevention launched Global heart Initiative in 2016.

Scope and Importance:
Hypertension is a significant public health concern of world-wide distribution and is also the most common cardiovascular disease risk factor. Hypertension or elevated blood pressure is a serious medical condition that significantly increases the risks of heart, brain, kidney and other diseases. An estimated 1.13 billion people worldwide have hypertension, most (two-thirds) living in low- and middle-income countries. Randomized controlled trials have shown that controlling hypertension reduces the risk of stroke, coronary artery disease, congestive heart failure, end-stage renal disease, peripheral vascular disease, as well as overall mortality. Hypertension depends on the knowledge and aptitudes to Cardiology and Cardiac Care. The patients of all age groups can be affected.  Cardiologist and hypertension specialists treat a large number of patients and decide according to their conditions in most of the modern emergency situations. The scope study of this report includes a key market analysis, market drivers, industry constraints, competitive developments and market trends. Research analyses each market segment and its applications, regulatory environment, technology, market projections and market shares. A complete geographical analysis of the market is also presented in the report. The emerging market for cardiology and ambulatory includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand. Profiles of key market players are also covered in this report.

Universities in USA:

• Harvard University, USA
• Duke University, USA
• Columbia University, USA
• Icahn School of Medicine at Mount Sinai, USA
• University of Toronto, Canada
• Stanford University, USA
• Johns Hopkins University, USA
• Boston University, USA
• University of Pennsylvania, USA
• University of Washington, USA
• University of Michigan, USA

Universities in Europe:

• St George's, University of London, UK
• Institute of Medical and Biomedical Education, UK
• University of Chester, England
• Institute of Medicine, UK
• University of Hertfordshire, UK
• Postgraduate Medicine, England
• Middlesex University, UK
• Queen Mary University of London, England
• Trinity College Dublin, Ireland
• University of Edinburgh, Scotland
• Harper Adams University, UK

Universities in Asia:

• University of Tokyo, Japan
• National University of Singapore, Singapore
• Kyoto University, Japan
• University of Hong Kong, China
• Peking University, China
• Seoul National University, South Korea
• National Taiwan University, Taiwan
• Osaka University, China
• Tsinghua University, China
• Taipei Medical University, Taiwan
• Mahidol University, Thailand
• University of the Philippines, Philippines
• Bandung Institute of Technology, Indonesia
• Universiti Putra Malaysia, Malaysia

Universities in Middle East:

• Alfaisal University, Saudi Arabia
• RAK Medical & Health Sciences University, UAE
• Gulf Medical University, UAE
• Hashemite University, Jordan
• Hawler Medical University, Iraq
• The Holy Spirit University of Kaslik, Lebanon
• Ain Shams University Faculty of Medicine, Egypt
• Ben-Gurion University of the Negev Medical School for International Health, Israe
• Kuwait University, Kuwait
• Sultan Qaboos University, Oman

Top Cardiology Hospitals in the World:

• Cleveland Clinic, Florida
• Mayo Clinic, Rochester
• Cedars-Sinai Medical Center, Los Angeles
• New York-Presbyterian Hospital-Columbia and Cornell, New York City
• Massachusetts General Hospital, Boston
• Mount Sinai Hospital, New York City
• Brigham and Women's Hospital, Boston
• University of California, California
• Los Angeles Medical Center, Los Angeles
• Stanford Health Care-Stanford Hospital, USA
• Northwestern Memorial Hospital, Chicago

Conclusion:
Hypertension is a very important disorder in aged people and is associated with higher risk of cardiovascular morbidity and mortality. The fact of reducing blood pressure values decreases the risk for cardiac death as well as neurological, metabolic, and musculoskeletal system sequelae in aged people. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. The best way to help prevent a stroke is to eat a healthy diet

We are announcing the Young Scientist Awards through the 3^rd International Conference on Hypertension which is scheduled on May 19-20, 2025 in Dubai, UAE. This Hypertension 2025 focuses on “Discovering the latest advancements in Hypertension”.
Hypertension and upcoming conferences will recognize participants who have significantly added value to the scientific community of Medical science and provide them with outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researchers by meeting experts to exchange and share their experiences at our international conferences.
Hypertension 2025 focuses mainly on hypertension and obesity, Artificial Intelligence in Hypertension, Wearable Devices for Blood Pressure Monitoring, Stress Management Techniques, and Novel Pharmacological Interventions etc.

Hypertension 2025 operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, Ph.D. students, and trainees to showcase their research and innovation.
Eligibility:
Young Scientists, faculty members, post-doctoral fellows, Ph.D. scholars, and bright Final Year MSc and M.Phil. Candidates and Persons from Scientific Industry can also participate.
Benefits:
The Young Scientist Feature is a platform to promote young researchers in their respective areas by giving them a chance to present their achievements and future perspectives.
Acknowledgment as YRF Awardee
Promotion on the conference website, Young Scientist Awards and certificates
Link on the conference website
Recognition on Meetings Int. Award Page
Chances to coordinate with partners around the world
Research work can be published in the relevant journal without any publication fee
Criteria:
All presented abstracts will automatically be considered for the Award.
All the presentations will be evaluated in the conference venue.
All the awards will be selected by the judges of the award category.
The winners of the Young Scientist Award will receive an award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.
Guidelines:
All submissions must be in English.
The topic must fit into the scientific sessions of the conference
Each individual participant is allowed to submit maximum 2 papers
The abstract must be submitted online as per the given abstract template
Abstracts must be written in Times New Roman and font size will be 12
The abstract must contain the title, name, affiliation, country, speakers biography, recent photograph, image, and reference
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication on the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of the award.
Award Announcements:
The official announcement of the recipients will occur after the completion of Hypertension 2025

Meetings Int. is a worldwide pioneer in delivering top-notch gatherings, workshops, and symposia in every significant field of science, innovation, and medication worldwide receiving 400,000+ online visitors with 1000+ sessions which confirms the outstanding pool of new users and visitors creating a platform to build your market place globally. Since its initiation, Meetings Int. has been related to national and global affiliations, organizations, and elevated-level people, committed to having world-class meetings and occasions so it provides a big platform to show your product and advertising. The explorer’s traffic is the benchmark for advertisement, and the Hypertension Conference website is continually dragged worldwide. As specified by Google Analytics, in excess of 12,836 researchers and industrials are visiting our conference sites. Hypertension 2025 virtual seminar helps you put the spotlight on your brand by advertising with more than 9 million+ readers worldwide about 5 million+ hits every month on our site. We provide an excellent opportunity to boost your business on our platform. We offer a range of eye-catching advertising spaces and branding. Researchers from powerful nations including the United States, Japan, United Kingdom, India, France, Taiwan, and Germany, etc.  Visit our conference site. Subscribers and conference attendees can be your upcoming enthusiastic customers. We maintain high quality and ethical standards in the event industry, which makes us unique and better than the rest. Advertisement banners must be provided by the advertising company and in jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.